Zimmer Biomet (ZBH)
(Real Time Quote from BATS)
$106.94 USD
+0.70 (0.66%)
Updated Sep 18, 2024 03:20 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Price, Consensus and EPS Surprise
ZBH 106.94 +0.70(0.66%)
Will ZBH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZBH
Why Is Zimmer (ZBH) Down 3.9% Since Last Earnings Report?
Should You Consider Retaining ZBH Stock in Your Portfolio Now?
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Market Share Gains Aid Zimmer Biomet Stock Amid Cost Pressure
Stereotaxis (STXS) Achieves CE Mark in Europe for GenesisX
Zimmer Biomet's (ZBH) Latest Deal to Expand Its Hip Portfolio
Other News for ZBH
FDA issues alert for increased risk of fracture after surgery with CPT System
Hold Rating on Zimmer Biomet Amid ERP Implementation Challenges and Revised Financial Projections
Zimmer Biomet hip replacement system subject of FDA alert
Zimmer Biomet price target lowered by $5 at JPMorgan, here's why
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH) and 23andMe Holding (ME)